Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Flexion Therapeutics (FLXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 695,132
  • Shares Outstanding, K 37,820
  • Annual Sales, $ 360 K
  • Annual Income, $ -137,480 K
  • 36-Month Beta 0.74
  • Price/Sales 1,978.15
  • Price/Cash Flow N/A
  • Price/Book 3.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -1.24
  • Number of Estimates 4
  • High Estimate -1.14
  • Low Estimate -1.35
  • Prior Year -1.07
  • Growth Rate Est. (year over year) -15.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.26 +4.55%
on 09/26/18
20.61 -12.45%
on 09/17/18
-2.67 (-12.91%)
since 09/14/18
3-Month
17.26 +4.55%
on 09/26/18
27.84 -35.18%
on 07/18/18
-8.94 (-33.14%)
since 07/13/18
52-Week
17.26 +4.55%
on 09/26/18
29.10 -37.99%
on 06/20/18
-7.49 (-29.32%)
since 10/13/17

Most Recent Stories

More News
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to three new employees for an aggregate of 20,600 shares of common stock. The Compensation Committee of the...

FLXN : 18.06 (-1.74%)
Downtrend Call Working As Flexion Therapeu Stock Falls 23.3% (FLXN)

SmarTrend identified a Downtrend for Flexion Therapeu (NASDAQ:FLXN) on July 27th, 2018 at $24.22. In approximately 2 months, Flexion Therapeu has returned 23.27% as of today's recent price of $18.58.

FLXN : 18.06 (-1.74%)
21.3% Return Seen to Date on SmarTrend Flexion Therapeu Call (FLXN)

SmarTrend identified a Downtrend for Flexion Therapeu (NASDAQ:FLXN) on July 27th, 2018 at $24.22. In approximately 2 months, Flexion Therapeu has returned 21.30% as of today's recent price of $19.06.

FLXN : 18.06 (-1.74%)
Flexion Therapeu Has Returned 19.8% Since SmarTrend Recommendation (FLXN)

SmarTrend identified a Downtrend for Flexion Therapeu (NASDAQ:FLXN) on July 27th, 2018 at $24.22. In approximately 2 months, Flexion Therapeu has returned 19.83% as of today's recent price of $19.42.

FLXN : 18.06 (-1.74%)
Flexion Therapeutics Announces Publication of Phase 2 Diabetes Data in September Issue of Rheumatology

-- Approximately 30% of patients with Type 2 diabetes also have osteoarthritis of the knee

FLXN : 18.06 (-1.74%)
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to four new employees for an aggregate of 10,500 shares of common stock. The Compensation Committee of the Board...

FLXN : 18.06 (-1.74%)
Flexion Therapeu Rises 4.18% on Heavy Volume: Watch For Potential Pullback

Flexion Therapeu (NASDAQ:FLXN) traded in a range yesterday that spanned from a low of $21.15 to a high of $22.39. Yesterday, the shares gained 4.2%, which took the trading range above the 3-day high...

FLXN : 18.06 (-1.74%)
Flexion Therapeutics Announces Presentation of Phase 3 Data at Military Health System Research Symposium

-- Osteoarthritis is a leading cause of disability discharge from the military

FLXN : 18.06 (-1.74%)
Shares of Flexion Therapeu Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (FLXN , SPPI , BLCM , IONS , IMGN )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

SPPI : 13.82 (-4.03%)
BLCM : 5.07 (-2.50%)
FLXN : 18.06 (-1.74%)
Flexion Therapeutics (FLXN) Reports Q2 Loss, Lags Revenue Estimates

Flexion Therapeutics (FLXN) delivered earnings and revenue surprises of 4.92% and -4.12%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

FLXN : 18.06 (-1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade FLXN with:

Business Summary

Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United...

See More

Key Turning Points

2nd Resistance Point 19.58
1st Resistance Point 18.98
Last Price 18.06
1st Support Level 17.74
2nd Support Level 17.10

See More

52-Week High 29.10
Fibonacci 61.8% 24.58
Fibonacci 50% 23.18
Fibonacci 38.2% 21.78
Last Price 18.06
52-Week Low 17.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar